Annual report
6960.TEDINET S100R73A
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥134.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥132.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥146.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥133.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥129.8bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥24.1bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥22.7bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥25.1bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥23.4bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥20.3bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.6bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥13.3bn | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥25.2bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥23.7bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥17.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥16.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥14.7bn | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.6bn | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.6bn | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥17.3bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥16.2bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥206.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥195.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥191.8bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥168.7bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥160.9bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥43.9bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥45.6bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥163.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥149.9bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥138.0bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥124.4bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥119.2bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥68.0bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥64.1bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥64.9bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥61.0bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥53.6bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥46.1bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥43.8bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥23.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥23.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥21.7bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥20.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥14.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥14.2bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥10.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥11.3bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥10.6bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥5.6bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥4.8bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥3.0bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.7bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.0bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥571.25 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥536.19 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥486.67 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥316.52 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥314.68 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥5,390.09 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,954.7 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,562.94 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥4,114.98 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥3,915.8 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 78.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 76.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 72.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 73.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.1% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 11.0% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.3% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 11.2% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.9% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.2% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 3,382 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 3,348 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 3,291 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 3,208 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 3,121 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥82.3bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥82.5bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥81.8bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥71.8bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥71.6bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥12.4bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥12.7bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥18.5bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥18.0bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥15.0bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥9.9bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥12.0bn | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥18.7bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥18.5bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥14.8bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥14.4bn | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥12.0bn | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8.0bn | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥9.5bn | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥176.0bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥163.5bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥158.1bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥137.3bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥131.4bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥48.8bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥46.5bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥127.2bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥117.1bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥107.2bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥96.7bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥92.8bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥46.1bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥41.3bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥489.27 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥477.6 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥397.01 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥264.8 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥312.95 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥240 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥305 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥275 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥180 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥175 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥4,204.87 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,871.21 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,543.95 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,199.28 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥3,048.24 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 72.3% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.6% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.8% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.4% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 70.6% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 12.1% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.9% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 11.8% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 8.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 10.6% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 39,176,000 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 39,176,000 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 39,176,000 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 39,176,000 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 39,176,000 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 690 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 669 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 659 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 651 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 629 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 64
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥100.1bn |
| Consumables And Other Productsreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Consumables And Other Productsreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥699m |
| Consumables And Other Productsreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥36.5bn |
| Consumables And Other Productsreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥36.5bn |
| Consumables And Other Productsreportable segment | segment assets | at 2023-03-31 | ¥25.7bn |
| Consumables And Other Productsreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥4.7bn |
| Medical Treatment Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥8.3bn |
| Medical Treatment Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥7.9bn |
| Medical Treatment Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥55.4bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥55.4bn |
| Medical Treatment Equipmentreportable segment | segment assets | at 2023-03-31 | ¥50.7bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥12.4bn |
| Patient Monitoring Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥417m |
| Patient Monitoring Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥222m |
| Patient Monitoring Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥11.6bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥11.6bn |
| Patient Monitoring Equipmentreportable segment | segment assets | at 2023-03-31 | ¥8.7bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| Physiological Diagnostic Equipmentreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥1.1bn |
| Physiological Diagnostic Equipmentreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥594m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥31.1bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥31.1bn |
| Physiological Diagnostic Equipmentreportable segment | segment assets | at 2023-03-31 | ¥21.7bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥4.9bn |
| —segment total | employees | at 2023-03-31 | 2691 pure |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥11.1bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥9.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥134.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥134.6bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥106.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥24.1bn |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥93.5bn |
| Consumables And Other Productsreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| Consumables And Other Productsreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥593m |
| Consumables And Other Productsreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥35.2bn |
| Consumables And Other Productsreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥35.2bn |
| Consumables And Other Productsreportable segment | segment assets | at 2022-03-31 | ¥24.1bn |
| Consumables And Other Productsreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥5.1bn |
| Medical Treatment Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥10.4bn |
| Medical Treatment Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥7.7bn |
| Medical Treatment Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥54.6bn |
| Medical Treatment Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥54.6bn |
| Medical Treatment Equipmentreportable segment | segment assets | at 2022-03-31 | ¥48.1bn |
| Medical Treatment Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥11.5bn |
| Patient Monitoring Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥655m |
| Patient Monitoring Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥217m |
| Patient Monitoring Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥12.9bn |
| Patient Monitoring Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥12.9bn |
| Patient Monitoring Equipmentreportable segment | segment assets | at 2022-03-31 | ¥9.9bn |
| Patient Monitoring Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥2.0bn |
| Physiological Diagnostic Equipmentreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Physiological Diagnostic Equipmentreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥495m |
| Physiological Diagnostic Equipmentreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥29.4bn |
| Physiological Diagnostic Equipmentreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥29.4bn |
| Physiological Diagnostic Equipmentreportable segment | segment assets | at 2022-03-31 | ¥19.9bn |
| Physiological Diagnostic Equipmentreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥4.1bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥14.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥9.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥132.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥132.1bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥102.0bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥22.7bn |
| —segment total | employees | at 2023-03-31 | 574 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,671
| Item | Context | Value | Unit |
|---|---|---|---|
| Total changes of items during the period | CurrentYearDuration_ValuationAndTranslationAdjustmentsMember | 1160000000 | JPY |
| Total changes of items during the period | CurrentYearDuration | 13190000000 | JPY |
| Net assets | CurrentYearInstant_ValuationDifferenceOnAvailableForSaleSecuritiesMember | 2395000000 | JPY |
| Net assets | CurrentYearInstant_ForeignCurrencyTranslationAdjustmentMember | 198000000 | JPY |
| Net assets | CurrentYearInstant_RemeasurementsOfDefinedBenefitPlansMember | 188000000 | JPY |
| Net assets | CurrentYearInstant_ValuationAndTranslationAdjustmentsMember | 2781000000 | JPY |
| Net assets | CurrentYearInstant | 163047000000 | JPY |
| Income before income taxes | Prior1YearDuration | 23724000000 | JPY |
| Income before income taxes | CurrentYearDuration | 25202000000 | JPY |
| Depreciation and amortization ope cf | Prior1YearDuration | 9016000000 | JPY |
| Depreciation and amortization ope cf | CurrentYearDuration | 9368000000 | JPY |
| Impairment loss ope cf | Prior1YearDuration | 127000000 | JPY |
| Impairment loss ope cf | CurrentYearDuration | 66000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YearDuration | -39000000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYearDuration | -20000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YearDuration | 245000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYearDuration | 513000000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | Prior1YearDuration | 143000000 | JPY |
| Increase decrease in provision for directors bonuses ope cf | CurrentYearDuration | -33000000 | JPY |
| Increase decrease in provision for product warranties ope cf | Prior1YearDuration | 44000000 | JPY |
| Increase decrease in provision for product warranties ope cf | CurrentYearDuration | -7000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YearDuration | 277000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYearDuration | 147000000 | JPY |
| Increase decrease in provision for share based remuneration for directors and other officers ope cf | Prior1YearDuration | 22000000 | JPY |
| Increase decrease in provision for share based remuneration for directors and other officers ope cf | CurrentYearDuration | 57000000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | Prior1YearDuration | 24000000 | JPY |
| Increase decrease in provision for directors retirement benefits ope cf | CurrentYearDuration | -73000000 | JPY |
| Interest and dividends income ope cf | Prior1YearDuration | -199000000 | JPY |
| Interest and dividends income ope cf | CurrentYearDuration | -253000000 | JPY |
| Interest expenses ope cf | Prior1YearDuration | 37000000 | JPY |
| Interest expenses ope cf | CurrentYearDuration | 37000000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | Prior1YearDuration | -4000000 | JPY |
| Loss gain on sales of noncurrent assets ope cf | CurrentYearDuration | -5000000 | JPY |
| Loss gain on investments in partnership ope cf | Prior1YearDuration | -63000000 | JPY |
| Loss gain on investments in partnership ope cf | CurrentYearDuration | -97000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YearDuration | -60000000 | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYearDuration | － | JPY |
| Loss gain on valuation of investment securities ope cf | Prior1YearDuration | － | JPY |
| Loss gain on valuation of investment securities ope cf | CurrentYearDuration | 45000000 | JPY |
| Loss gain on cancellation of insurance contract ope cf | Prior1YearDuration | -404000000 | JPY |
| Loss gain on cancellation of insurance contract ope cf | CurrentYearDuration | -173000000 | JPY |
| Loss gain on extinguishment of tie in shares ope cf | Prior1YearDuration | － | JPY |
| Loss gain on extinguishment of tie in shares ope cf | CurrentYearDuration | -67000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YearDuration | 6571000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYearDuration | -1612000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YearDuration | -599000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYearDuration | -1957000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YearDuration | -7041000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYearDuration | -1799000000 | JPY |
| Increase decrease in accrued consumption taxes ope cf | Prior1YearDuration | -499000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |